Signals
Platform Powered By EquityPandit

Cash Intraday
Signals

Option
Signals

Stock Future
Intraday Signals

Swing Trading
Signals

Investment
Opportunities

Stock
Signals

Join Now

Akums Drugs & Pharmaceuticals Ltd

NSE :AKUMS   BSE :544222  Sector : Pharmaceuticals
Buy, Sell or Hold AKUMS? Ask The Analyst

BSE

prev close

OPEN PRICE

bid price (qty)

offer price (qty)

volume

Today's low / high

52 WK low / high

NSE

prev close

open price

bid price (qty)

offer price (qty)

volume

Today's' low / high

52 WK low / high

13 Nov
612.70
(-5.00%)
12 Nov
644.95
(-10.00%)
11 Nov
716.60
(-10.00%)
08 Nov
796.20
(-0.77%)
07 Nov
802.40
(-0.69%)
06 Nov
808.00
(-2.97%)
05 Nov
832.70
(-1.48%)
04 Nov
845.25
(-1.22%)
01 Nov
855.65
(1.63%)
31 Oct
841.90
(-6.73%)
30 Oct
902.60
(1.54%)
29 Oct
888.90
(2.66%)
28 Oct
865.90
(2.08%)
25 Oct
848.25
(-3.09%)
24 Oct
875.30
(-1.00%)
23 Oct
884.15
(-2.19%)
22 Oct
903.95
(-1.29%)
21 Oct
915.75
(0.63%)
18 Oct
910.00
(-0.42%)
17 Oct
913.85
(-0.74%)
16 Oct
920.65
(4.55%)

Price Chart Historical Data Technical Chart

Technical Analysis

Short Term Investors

Very Bearish
Medium Term Investors

Very Bearish
Long Term Investors

Bullish

Moving Averages

5 DMA
Bearish

714.9

10 DMA
Bearish

775.7

20 DMA
Bearish

833.03

50 DMA
Bearish

850.84

100 DMA
Bullish

0

200 DMA
Bullish

0


Intraday Support and Resistance
(Based on Pivot Points) |

Updated On Nov 13, 2024 04:00 PM For Next Trading Session

Pivots Classic Fibonacci Camarilla Woodie DM
R3 658.2 649.1 620.21 - -
R2 649.1 638.67 617.71 646.83 -
R1 630.9 632.23 615.2 626.36 640
P 621.8 621.8 621.8 619.53 626.35
S1 603.6 611.37 610.2 599.06 612.7
S2 594.5 604.93 607.7 592.23 -
S3 576.3 594.5 605.19 - -

Key Metrics

EPS

4.12

P/E

148.8

P/B

4.32

Dividend Yield

0%

Market Cap

9,644 Cr.

Face Value

2

Book Value

142.04

ROE

-3.57%

EBITDA Growth

137.35 Cr.

Debt/Equity

0.83

Shareholding Pattern

  75.26% Total Promoter Holding
5.18% Mutual Fund Holdings
7.34% FIIs
7.15% Non Institution
1.72% Insurance Companies
2.73% Custodians
0.62% Other Parties

Shareholding History

Quarterly Result (Figures in Rs. Crores)


Akums Drugs & Pharmaceuticals Ltd Quaterly Results


Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
INCOME 1188.03 1091.29 954.67 1025.66 1050.26
PROFIT 42.1 192.78 -41.48 60.17 62.52
EPS 2.22 13.54 -2.89 4.21 4.37

Akums Drugs & Pharmaceuticals Ltd Quaterly Results


Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
INCOME 336.01 469.17 325.02 343.45 360.47
PROFIT -189.67 64.54 -56.81 41.88 50.37
EPS -13.26 3.69 -4.04 2.93 3.38

Profit & Loss (Figures in Rs. Crores)


Akums Drugs & Pharmaceuticals Ltd Profit & Loss


Mar 2014Mar 2015Mar 2016Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
INCOME 1153.27 1501.24 1683.22 2470.43 2791.59 3782.46 3720.85 4199.87
PROFIT 88.55 43.35 61.46 44.06 129.72 -243.55 127.36 -30.33
EPS 0 0 0 0 0 0 0 0

Akums Drugs & Pharmaceuticals Ltd Profit & Loss


Mar 2013Mar 2014Mar 2015Mar 2016Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
INCOME 814.72 921.3 993.94 631.95 661.63 749.93 793.91 881.31 1238.99 1430.01
PROFIT 100.6 105.76 84.55 43.97 67.72 73.42 50.84 110.32 -382.77 226.86
EPS 707.07 899.53 720.3 374.17 576.36 636.95 391.04 -1117.82 -53.37 8.77

Balance Sheet (Figures in Rs. Crores)

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2016Mar 2015Mar 2014
SOURCES OF FUNDS :
Share Capital 28.6128.6114.311.31.31.181.181.18
Reserves Total 680.89688.58607.67883.55721.1628.19492.84457.22
Total Shareholders Funds709.5717.19621.98884.85722.4629.37494.02458.4
Minority Interest10.996.193.22.29-1.5112.112.631.44
Secured Loans 391.33536.97357.9595.9139.83187.13234.13157.78
Unsecured Loans 173.8982.1237.0334.0735.0226.3120.658
Total Debt565.22619.09394.98129.97174.85213.44254.78165.78
Other Liabilities1,426.971,061.911,088.42629.49542.9231.8729.7326.2
Total Liabilities2,712.682,404.382,108.581,646.61,438.66886.79781.16651.82
APPLICATION OF FUNDS :
Gross Block 1,881.941,677.131,517.531,321.01992.96631.71541.88375.9
Less: Accumulated Depreciation691.18579.82496.99417.02348.02131.1997.5871.55
Net Block1,190.761,097.311,020.54903.99644.94500.52444.3304.35
Capital Work in Progress195.41103.1631.0717.0156.610.52021.77
Investments 0.140.140.3919.545.8417.900
Inventories 630.43729.8722.45429.86398.32288.72260.85191.53
Sundry Debtors 833.81845.09884.31531.4581.54259.12272.76241.46
Cash and Bank Balance277.05149.99102.8567.87147.3613.6811.8724.02
Loans and Advances 199.5154154.46109.27116.7918.9715.449.08
Total Current Assets1,940.791,878.871,864.061,138.391,244580.5560.91466.09
Current Liabilities 733.49772.15814.45410.53498.24227.95215.55160.39
Provisions 58.0364.71106.7268.4866.746.5419.746.88
Total Current Liabilities & Provisions791.52836.85921.17479.01564.98234.49235.29167.28
Net Current Assets1,149.261,042.02942.89659.38679.02346.01325.62298.81
Deferred Tax Assets206.0699.5754.6854.5541.476.066.060
Deferred Tax Liability95.1693.3575.1381.1174.6345.4731.4725.48
Net Deferred Tax110.96.22-20.45-26.56-33.16-39.41-25.41-25.48
Other Assets66.2155.53134.1473.2485.4151.2536.6452.37
Total Assets2,712.682,404.382,108.581,646.61,438.65886.79781.15651.82
Contingent Liabilities88.6281.5497.5122.490000
Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2016Mar 2015Mar 2014Mar 2013
SOURCES OF FUNDS :
Share Capital 28.6114.311.31.31.181.181.181.181.181.18
Reserves Total 282.89171.23565.75711.02840.65765.92664.88620.62535.98429.99
Total Shareholders Funds311.5185.54567.05712.32841.83767.1666.06621.8537.16431.17
Secured Loans 145.59122.0922.7135.851.0733.2749.9494.15126.0350.47
Unsecured Loans 42.5218.0718.42000127.586.055.49
Total Debt188.11140.1641.1335.851.0733.2761.94101.73132.0855.96
Other Liabilities1,023.51,063.07568.21513.6625.7924.2723.1622.3322.4521.19
Total Liabilities1,523.111,388.771,176.391,261.78918.69824.64751.16745.86691.69508.32
APPLICATION OF FUNDS :
Gross Block 539.75496.68463.21436.09389.04366.54335.42321.58324.37311.29
Less : Accumulated Depreciation 267.35243.49218.8194.41168.88147.3210484.2764.750.59
Net Block 272.4253.19244.41241.68220.16219.22231.42237.31259.67260.7
Capital Work in Progress16.250.521.261.13000000.7
Producing Properties000016.3516.860000
Investments 139.16141.39149.4665.353.883.9221.783.944.441.21
Inventories 197.12179.3195.91122.98106.17121.36120.0291.82160.86111.05
Sundry Debtors 256.13303.93211.66177.69158.88121.12116.32142.51191.13157.85
Cash and Bank Balance8.8525.74172.483.870.492.082.0121.152.89
Loans and Advances 58.9846.1943.02120.9932.8247.3916.5814.0510.916.47
Total Current Assets521.08555.16351.59494.14301.73290.36255250.4384.06278.25
Current Liabilities 365.36394.54104.15124.47104.29112.0763.4472.91130.84127.9
Provisions 5.7517.8417.8217.670.190.150.1414.135.255.9
Total Current Liabilities & Provisions371.11412.38121.97142.14104.48112.2263.5987.03136.1133.8
Net Current Assets149.97142.78229.62351.99197.25178.14191.42163.36247.96144.45
Deferred Tax Assets29.957.7965.210000005.96
Deferred Tax Liability26.8120.5931.4522.3323.1423.5922.5922.0323.526.52
Net Deferred Tax3.14-12.833.76-22.33-23.14-23.59-22.59-22.03-23.5-20.56
Other Assets942.18863.69517.88623.97504.18430.08329.12363.27203.12121.81
Total Assets1,523.11,388.771,176.391,261.79918.68824.63751.15745.85691.69508.31
Contingent Liabilities187.8834.5831.530000000

Cash Flow (Figures in Rs. Crores)

Net Profit before Tax and Extr...-45.28
Depreciation125.64
Interest (Net)38.62
P/L on Sales of Assets0.32
Prov. and W/O (Net)8.71
Total Adjustments (PBT and Ext...556.09
Operating Profit before Workin...510.81
Trade and 0ther Receivables-3.23
Inventories83.73
Trade Payables-29.2
Total Adjustments (OP before W...49.87
Cash Generated from/(used in) ...560.68
Direct Taxes Paid-62.42
Total Adjustments(Cash Generat...-62.42
Cash Flow before Extraordinary...498.26
Net Cash from Operating Activi...498.26
Purchased of Fixed Assets-311.41
Sale of Fixed Assets24.99
Interest Received12
Net Cash used in Investing Act...-330.8
Proceed from 0ther Long Term B...10.29
Of the Long Tem Borrowings-35.86
Of the Short Term Borrowings-23.63
Of Financial Liabilities-15.39
Interest Paid-43.44
Net Cash used in Financing Act...-108.02
Net Profit before Tax and Extr...150.32
Depreciation30
Interest (Net)-48.57
P/L on Sales of Assets-4.64
P/L on Sales of Invest3.78
Prov. and W/O (Net)128.34
Total Adjustments (PBT and Ext...55.51
Operating Profit before Workin...205.83
Trade and 0ther Receivables46.43
Inventories-17.81
Trade Payables-74.14
Total Adjustments (OP before W...-81.51
Cash Generated from/(used in) ...124.31
Direct Taxes Paid-30.3
Total Adjustments(Cash Generat...-30.3
Cash Flow before Extraordinary...94.01
Net Cash from Operating Activi...94.01
Purchased of Fixed Assets-116.26
Sale of Fixed Assets12.83
Sale of Investments3.43
Interest Received60.03
Loans to Subsidiaires-164.41
Acquisition of Companies-1.55
Net Cash used in Investing Act...-202.17
Proceed from 0ther Long Term B...25
Proceed from Short Tem Borrowi...79.75
Of Financial Liabilities-4.22
Interest Paid-10.63
Net Cash used in Financing Act...89.9

Company Details

Registered Office
Address304 Mohan Place LSC Saraswati,
Vihar
CityDelhi
StateDelhi
Pin Code110034
Tel. No.+91 11 6904 1000
Fax. No.
Emailcs@akums.net
Internethttp://www.akums.in
Registrars
Address304 Mohan Place LSC Saraswati
CityDelhi
StateDelhi
Pin Code110034
Tel. No.+91 11 6904 1000
Fax. No.
Emailcs@akums.net
Internethttp://www.akums.in
Management
Name Designation
SANDEEP JAINManaging Director
SANJEEV JAINManaging Director
Matangi GowrishankarIndependent Director
Dharamvir MalikCompany Sec. & Compli. Officer
Kewal Kundanlal HandaIndependent Director
NAND LAL KALRAIndependent Director
Sanjay SinhaWhole-time Director
SUNIL KUMAR THAKURNon Executive Director
SATWINDER SINGHIndependent Director